Literature DB >> 17440193

The incidence and risks of liver biopsy in non-cirrhotic patients: An evaluation of 3806 biopsies.

Jee-Fu Huang, Ming-Yen Hsieh, Chia-Yen Dai, Nai-Jen Hou, Li-Po Lee, Zu-Yau Lin, Shinn-Chern Chen, Liang-Yen Wang, Ming-Yuh Hsieh, Wen-Yu Chang, Ming-Lung Yu, Wan-Long Chuang.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17440193      PMCID： PMC1942123          DOI： 10.1136/gut.2006.115410

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  3 in total

1.  Twenty-year audit of percutaneous liver biopsy in a major Australian teaching hospital.

Authors:  D van der Poorten; A Kwok; T Lam; L Ridley; D B Jones; M C Ngu; A U Lee
Journal:  Intern Med J       Date:  2006-11       Impact factor: 2.048

2.  Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London.

Authors:  I T Gilmore; A Burroughs; I M Murray-Lyon; R Williams; D Jenkins; A Hopkins
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

3.  Early discharge after core liver biopsy: is it safe and cost-effective?

Authors:  Simon G Bicknell; Jonathon Richenberg; Peter L Cooperberg; Pari Tiwari; Laurence Halperin
Journal:  Can Assoc Radiol J       Date:  2002-10       Impact factor: 2.248
  3 in total
  17 in total

1.  Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines.

Authors:  Carla S Coffin; Scott K Fung; Mang M Ma
Journal:  Can J Gastroenterol       Date:  2012-12       Impact factor: 3.522

2.  Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial.

Authors:  Leonard B Seeff; Gregory T Everson; Timothy R Morgan; Teresa M Curto; William M Lee; Marc G Ghany; Mitchell L Shiffman; Robert J Fontana; Adrian M Di Bisceglie; Herbert L Bonkovsky; Jules L Dienstag
Journal:  Clin Gastroenterol Hepatol       Date:  2010-04-01       Impact factor: 11.382

3.  Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial.

Authors:  Gregory T Everson; Mitchell L Shiffman; John C Hoefs; Timothy R Morgan; Richard K Sterling; David A Wagner; Shannon Lauriski; Teresa M Curto; Anne Stoddard; Elizabeth C Wright
Journal:  Hepatology       Date:  2012-03-01       Impact factor: 17.425

4.  Adequacy of percutaneous non-targeted liver biopsy under real-time ultrasound guidance when comparing the Biopince™ and Achieve™ biopsy needle.

Authors:  Thomas C Hall; Claire Deakin; Gurprit Ss Atwal; Rajeev K Singh
Journal:  Br J Radiol       Date:  2017-10-03       Impact factor: 3.039

Review 5.  Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B.

Authors:  Masaru Enomoto; Hiroyasu Morikawa; Akihiro Tamori; Norifumi Kawada
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

6.  Evaluation of Risk Factors for Bleeding After Ultrasound-Guided Liver Biopsy.

Authors:  Haoyu Jing; Zhanxiong Yi; Enhui He; Ruifang Xu; Xianquan Shi; Li Li; Liying Sun; Ying Liu; Liang Zhang; Linxue Qian
Journal:  Int J Gen Med       Date:  2021-09-11

7.  Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound-detected liver nodules.

Authors:  Maria Stella Franzè; Antonio Bottari; Simona Caloggero; Alessia Pitrone; Adalberto Barbera; Tindaro Lembo; Gaia Caccamo; Irene Cacciola; Sergio Maimone; Angela Alibrandi; Concetta Pitrone; Giovanni Squadrito; Giovanni Raimondo; Carlo Saitta
Journal:  Intern Emerg Med       Date:  2020-10-27       Impact factor: 3.397

8.  A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B.

Authors:  Wai-Kay Seto; Ching-Lung Lai; Philip P C Ip; James Fung; Danny Ka-Ho Wong; John Chi-Hang Yuen; Ivan Fan-Ngai Hung; Man-Fung Yuen
Journal:  PLoS One       Date:  2012-02-28       Impact factor: 3.240

9.  Safety and effectiveness of blind percutaneous liver biopsy: analysis of 1412 procedures.

Authors:  Aleksandra Szymczak; Krzysztof Simon; Malgorzata Inglot; Andrzej Gladysz
Journal:  Hepat Mon       Date:  2012-01-20       Impact factor: 0.660

10.  Percutaneous ultrasonographically guided liver punctures: an analysis of 1961 patients over a period of ten years.

Authors:  Michael Mueller; Wolfgang Kratzer; Suemeyra Oeztuerk; Manfred Wilhelm; Richard Andrew Mason; Ren Mao; Mark Martin Haenle
Journal:  BMC Gastroenterol       Date:  2012-12-05       Impact factor: 3.067
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.